A detailed history of Jump Financial, LLC transactions in Biogen Inc. stock. As of the latest transaction made, Jump Financial, LLC holds 56,669 shares of BIIB stock, worth $8.44 Million. This represents 0.24% of its overall portfolio holdings.

Number of Shares
56,669
Previous 7,705 635.48%
Holding current value
$8.44 Million
Previous $1.79 Million 515.01%
% of portfolio
0.24%
Previous 0.04%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$189.07 - $236.8 $9.26 Million - $11.6 Million
48,964 Added 635.48%
56,669 $11 Million
Q2 2024

Aug 14, 2024

SELL
$190.52 - $236.72 $10.7 Million - $13.3 Million
-56,061 Reduced 87.92%
7,705 $1.79 Million
Q1 2024

May 13, 2024

BUY
$212.02 - $267.71 $13.2 Million - $16.7 Million
62,429 Added 4669.33%
63,766 $13.7 Million
Q4 2023

Oct 21, 2024

SELL
$222.59 - $267.94 $177,626 - $213,816
-798 Reduced 37.38%
1,337 $345,000
Q4 2023

Feb 07, 2024

BUY
$222.59 - $267.94 $297,602 - $358,235
1,337 New
1,337 $345,000
Q2 2023

Oct 21, 2024

SELL
$275.25 - $318.06 $1.53 Million - $1.77 Million
-5,570 Reduced 72.29%
2,135 $608,000
Q2 2023

Aug 07, 2023

BUY
$275.25 - $318.06 $587,658 - $679,058
2,135 New
2,135 $608,000
Q3 2022

Nov 07, 2022

SELL
$194.69 - $268.46 $2.94 Million - $4.06 Million
-15,109 Reduced 94.23%
925 $247,000
Q2 2022

Aug 09, 2022

BUY
$187.54 - $223.02 $2.83 Million - $3.36 Million
15,079 Added 1578.95%
16,034 $3.27 Million
Q1 2022

May 12, 2022

SELL
$193.77 - $244.14 $83,127 - $104,736
-429 Reduced 31.0%
955 $201,000
Q4 2021

Feb 10, 2022

BUY
$223.92 - $287.77 $309,905 - $398,273
1,384 New
1,384 $332,000
Q3 2021

Nov 12, 2021

SELL
$282.99 - $369.05 $303,931 - $396,359
-1,074 Closed
0 $0
Q2 2021

Aug 13, 2021

BUY
$259.0 - $414.71 $278,166 - $445,398
1,074 New
1,074 $372,000

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $21.5B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Jump Financial, LLC Portfolio

Follow Jump Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jump Financial, LLC with notifications on news.